Author

Camille Combe

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Anaïs Vermare· 1 shared Andrea ValentiniiD· 1 shared Biagio De AngelisiD· 1 shared Concetta QuintarelliiD· 1 shared Dongjie AniD· 1 shared Emmanuel DonnadieuiD· 1 shared Frédéric PendinoiD· 1 shared Josquin MoralyiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anaïs Vermare

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

An in vivo CRISPR screen unveils top target genes to improve CAR-T cell efficacy in a solid tumor model

Mattia Fumagalli, Dongjie An, Luca Simula, Camille Combe, Lisa Aziez, Yannick Simoni, Marie‐Clotilde Alves‐Guerra, Andrea Valentini, Maude Marchais, Anaïs Vermare, Josquin Moraly, Simona Manni, Maria Cecilia Quadraccia, Concetta Quintarelli, Biagio De Angelis, , Frédéric Pendino

This study uses an in vivo CRISPR screen to identify genes that enhance CAR-T cell efficacy in a solid tumor model, finding that disrupting REGNASE-1, SOCS1, PTPN2, and P16/NK4A improves tumor eradication.

Molecular Therapy · Apr 4, 2026Peer-reviewedImmunology